Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NJ Bio Inc. and Charles River Partner to Offer ADC Services | Contract Pharma
Breaking News, Collaborations & Alliances

NJ Bio Inc. and Charles River Partner to Offer ADC Services

Alliance aims to advance ADC development and manufacturing services.

NJ Bio Inc. and Charles River Laboratories Inc. have entered a strategic alliance to offer complementary services to clients including early development and optimization to manufacturing of antibody-drug conjugates (ADCs).

 
The partnership aims to offer seamless complementary services to enhance outcomes and accelerate time-to-market for ADCs. Additionally, this alliance enables Charles River to innovate with engineered antibodies, while NJ Bio focuses on synthesizing and manufacturing new linkers, payloads, or linker-payload combinations, to help  improve the safety and effectiveness of ADCs.
 
Charles River provides antibody development and preclinical evaluation of ADCs. The company’s antibody, oncology, immunology and safety assessment services support ADC programs from proof-of-concept to clinical candidates.
 
NJ Bio Inc. specializes in providing integrated chemistry and bioconjugation services, with expertise in the synthesis and GMP manufacturing of payloads, linkers, linker-payloads, ADCs, TPDs, and oligo-conjugates, and non-oncology related conjugations. NJ Bio supports early phase discovery, proof-of-concept, process and analytical development, manufacture of preclinical batches, and manufacture and release of linkers, payloads, linker-payloads, and ADCs form its GMP facility.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters